We reviewed a total of 23 cases of multiple myeloma that were treated in our hospital during the six-year period between January 1978 and December 1983. It was found that the majority of the multiple myeloma patients (52.2%) had complained of pain in the lumbar spine area when they visited our office. It was also made clear that it had taken considerably long before definitive diagnosis for those patients with low back pain when compared with the patients with other complaints.
Furthermore, we went over the results of some of the routine tests conducted at their first visits. These tests are often included in the mass health screening program.
We found that ZTT levels were abnormal in 90.9% of the multiple myeloma patients, Ch-E in 82.6% and A/G ratio in 73.9%.
These resuits suggest that doctors should suspect multiple myeloma and indicate further examinations when ZTT values were found abnormally high or low among elderly people complaining of low back pain by clinial or mass health examination.

A recently licensed opioid, Abstral^®, a rapid-acting sublingual tablet of fentanyl, is different from other opioids in its complicated usage. The points to consider are; a careful titration grounded on the assessment whether the increase of base or rescue is appropriate, setting up the tentative upper limit suitable for the baseline opioid, the differentiation of the concept between the rescue dose and the additional dose, instruction to the medical stuff as well as patients and family and cost benefit balance. Taking account of these points, we recommend introducing Abstral^® in our hospital to patients who have difficulty in swallowing or other gastrointestinal function only in the wards. The palliative care team, the department of pharmacy and the division of nursing collaborated to let the medical stuff know these concerns and introduced a license system in which only those doctors who receive an intensive course on the use of Abstral^® can prescribe it. At the same time, we gave a lecture for the nurses and other medical stuff repeatedly (ten times) so as to include as many as possible. A monitoring system of Abstral^® prescription is also established in our hospital.

Purposes: This report describes our activities of performing aromatherapy massage for cancer patients in the general ward. Methods: The number of patients, sex, age, aroma treatment times, outcome, disease type, performance status (PS), treatment phase, symptoms, massage site, and oil type were investigated using the clinical records from March 2014 to March 2016. Results: Aromatherapy massage was performed for 116 patients a total of 301 times. With regard to the final outcome, 50 patients were moved to the palliative care unit (PCU), whereas 49 patients died in the general ward. The main symptoms were general malaise, edema, pain, and anxiety. The popular massage sites were lower limbs, back, and upper limbs. The preferred oils were citrus and relaxation-inducing type. Discussion: By joining the palliative care team, certified aromatherapy nurses were allowed to perform the aromatherapy massage on more patients in the general ward than before. The need for aromatherapy massage was found not only in terminally ill patients but also in chemotherapy patients with good PS. In addition, for patients who were moved to the PCU, aromatherapy massage functioned as bridge between the general ward and PCU because one of the aromatherapy nurses worked in the PCU.

Although continuous deep sedation (CDS) is sometimes used for terminally ill cancer patients to alleviate intolerable symptoms, there are few studies that comprehensively investigated CDS in general ward, including the rate of discussions by multiple occupations. The aim of this study was to retrospectively investigate the present state of CDS for patients in the general ward who were referred to the palliative care team (PCT). A total of 938 terminal cancer patients who were consulted with PCT between August 2012 and October 2015 were enrolled. Of the 938 patients enrolled in the study, 246 patients died in the general ward before the end of November 2015. Of the 246 patients, 28 patients (11.4%) were treated with CDS to alleviate intolerable symptoms in the terminal period. The mean duration of CDS was 4.1±3.1 days. Lung cancer was the most common in primary disease. The primary reason for starting CDS was dyspnea. All CDS were performed with midazolam. The discussions on CDS by multiple occupations were performed in all cases. We conclude that on weekdays the PCT visited the patient every day and was able to sedate all cases with sedation discussion by multiple occupations.

OBJECTIVE: This study was conducted to ascertain the correlation between preserved pelvic nerve networks and bladder function after laparoscopic nerve-sparing radical hysterectomy. METHODS: Between 2009 and 2011, 53 patients underwent total laparoscopic radical hysterectomies. They were categorized into groups A, B, and C based on the status of preserved pelvic nerve networks: complete preservation of the pelvic nerve plexus (group A, 27 cases); partial preservation (group B, 13 cases); and complete sacrifice (group C, 13 cases). To evaluate bladder function, urodynamic studies were conducted preoperatively and postoperatively at 1, 3, 6, and 12 months after surgery. RESULTS: No significant difference in sensory function was found between groups A and B. However, the sensory function of group C was significantly lower than that of the other groups. Group A had significantly better motor function than groups B and C. No significant difference in motor function was found between groups B and C. Results showed that the sensory nerve is distributed predominantly at the dorsal half of the pelvic nerve networks, but the motor nerve is predominantly distributed at the ventral half. CONCLUSION: Various types of total laparoscopic nerve-sparing radical hysterectomies can be tailored to patients with cervical carcinomas.
Adult ; Aged ; Female ; Humans ; Hypogastric Plexus/injuries ; Hysterectomy/adverse effects/*methods ; Laparoscopy/adverse effects/*methods ; Middle Aged ; Neoplasm Staging ; Pelvis/innervation ; Peripheral Nerve Injuries/etiology/*prevention & control ; Postoperative Period ; Urinary Bladder/*innervation/physiopathology ; Urodynamics ; Uterine Cervical Neoplasms/pathology/*surgery